20th Annual International Congress on Hematologic Malignancies : Focus on Leukemias, Lymphomas and Myeloma

20th Annual International Congress on Hematologic Malignancies : Focus on Leukemias, Lymphomas and Myeloma is organized by Physicians Education Resource, LLC (PER) and would be held during Mar 18 - 20, 2016 at Eden Roc Miami, Miami, Florida, United States of America. The targeted audience for this medical event basically for hematologists and medical oncologists, Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, and other healthcare professionals.

The main focus of this medical conference is focus on key clinical topics in the field, with a particular focus on leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, benign hematologic disorders, and mitigation and management of adverse events. This CME conference has been approved with 19.0 AMA PRA Category 1 Credits.

Learning Objectives
At the conclusion of this symposium, you should be better prepared to:
• Describe current and evolving genomic and molecular biomarkers that can be used to stratify risk and inform clinical decision-making in the management of hematologic malignancies
• Assess landmark clinical trial results in the context of how they impact evolving clinical practice paradigms and can be applied to personalize care and optimize outcomes
• Delineate effective strategies to proactively mitigate and manage predictable side effects related to the management of hematologic malignancies so that treatment outcomes can be maximized
• Evaluate recent clinical trial findings concerning novel compounds or strategies to manage hematologic malignancies
• Consider the therapeutic implications of emerging data on evolving treatment paradigms for patients with hematologic tumors